nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-3670FE11·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.1 Basic medicine·Subfield: Cell Biology·Basis: Full text·Type: Laboratory experiment

The fate of human SUSD2+ endometrial mesenchymal stem cells during decidualization

Tina Gorsek Sparovec et al.Tina Gorsek Sparovec, Udo R Markert, Philipp Reif et al.·2022·Stem Cell Research·10.1016/j.scr.2022.102671 ↗

Primary claim

Our results suggest that SUSD2+ eMSC undergo decidualization in vitro, while maintaining MSC plasma membrane phenotype.

Tentative · decidual secretion supports a response, but small surface-marker comparisons and 20.3% CD45 positivity undermine maintenance of the stated MSC phenotype
In brief

Cultured SUSD2-positive endometrial cells show a decidual secretory response, but assay and identification problems undermine claims about preserved stemness and cell transition.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

Regeneration of the endometrial stromal compartment in premenopausal women is likely maintained by the perivascular endometrial mesenchymal stem/stromal cells (eMSC) expressing sushi domain containing 2 (SUSD2). The fate of SUSD2+ eMSC during pregnancy and their role in decidualization is not fully known. The aim of our study was to determine the effect of progesterone on the stemness of the SUSD2+ eMSC isolated from non-pregnant uterine samples. Secondary objectives were to characterize the functional capacity including differentiation and clonogenicity assays of SUSD2+ eMSC isolated from decidua at full term and compare it to the capacity of those isolated from non-pregnant uterine samples. Progesterone treatment induced changes in the decidual gene expression profile in non-pregnant SUSD2+ eMSC. Data analysis of a publicly available single cell RNA-seq data set revealed differential expression of several mesenchymal and epithelial signature genes between the SUSD2+ eMSC and the decidual stromal cells, suggesting mesenchymal-to-epithelial transition occurs during decidualization. Histological analysis revealed a significantly lower abundance of SUSD2+ eMSC in 1st trimester and full term samples compared to non-pregnant samples, p = 0.0296 and 0.005, respectively. The differentiation and the colony forming capacity did not differ significantly between the cells isolated from non-pregnant and pregnant uterine samples. Our results suggest that SUSD2+ eMSC undergo decidualization in vitro, while maintaining MSC plasma membrane phenotype. Human eMSC seem to play an important role in the course of endometrial decidualization and embryo implantation. Pregnancy reduced the abundance of SUSD2+ eMSC, however eMSC function remains intact.

Key Claims

Primary finding · Tentative

Our results suggest that SUSD2+ eMSC undergo decidualization in vitro, while maintaining MSC plasma membrane phenotype.

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

decidual secretion supports a response, but small surface-marker comparisons and 20.3% CD45 positivity undermine maintenance of the stated MSC phenotype

Abstract; Section 3.4, Figures 4–5
Quote verified
Secondary · Tentative

Progesterone treatment induced changes in the decidual gene expression profile in non-pregnant SUSD2+ eMSC.

combined progestin–cAMP treatment prevents attribution of the gene-expression response to progesterone alone

Abstract; Section 3.4, Figure 5A
Quote verified
Secondary · Tentative

Histological analysis revealed a significantly lower abundance of SUSD2+ eMSC in 1st trimester and full term samples compared to non-pregnant samples, p = 0.0296 and 0.005, respectively.

cross-sectional stained-area fractions cannot distinguish cell abundance from tissue-composition effects

Abstract; Section 3.1, Figure 1B
Quote verified
Secondary · Tentative

Pregnancy reduced the abundance of SUSD2+ eMSC, however eMSC function remains intact.

cross-sectional sampling and small functional comparisons after culture expansion cannot establish pregnancy-induced loss or preserved in vivo function

Abstract; Sections 3.2–3.3; Discussion
Quote verified
Secondary · Tentative

Data analysis of a publicly available single cell RNA-seq data set revealed differential expression of several mesenchymal and epithelial signature genes between the SUSD2+ eMSC and the decidual stromal cells, suggesting mesenchymal-to-epithelial transition occurs during decidualization.

a static comparison of distinct cell populations with conflicting marker patterns cannot identify a lineage transition

Abstract; Section 3.6, Figure 6D; Discussion
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#methodological rigour

Decidual secretion measured in donor cultures

PRL and IGFBP1 secretion increased after combined progestin–cAMP treatment in both SUSD2-positive and SUSD2-negative cultures. Measurements were normalized to cell number.

↳ Sections 2.9, 2.12 and 3.5; Figure 5B–C

#contribution

Term decidua extends the descriptive comparison

The study compares clonogenicity and differentiation in cells isolated from term decidua parietalis and non-pregnant endometrium, extending the tissue-stage characterization of SUSD2-positive cells.

↳ Sections 3.1–3.3; Figures 1–2

#positioning

Conflicting prior findings receive explicit discussion

The Discussion identifies the failure to reproduce an earlier difference in decidual secretion and acknowledges epithelial-marker results that oppose the proposed transition.

↳ Discussion, Murakami comparison and MET-marker interpretation

Limitations

#methodological rigour

Population purity and differentiation controls remain unresolved

The gated population averaged 20.3% CD45-positive cells despite the paper's CD45-negative MSC definition. Untreated controls also showed myocyte differentiation, limiting that assay's specificity.

↳ Introduction; Sections 3.2 and 3.4; Figures 2 and 4

#methodological rigour

Experimental contrasts cannot identify broader biological claims

Static cell-cluster comparisons do not establish a lineage transition, combined MPA–cAMP treatment cannot isolate progesterone effects, and stained-area fractions do not directly identify changes in cell abundance.

↳ Sections 2.4, 2.9, 2.13 and 3.6; Figures 1 and 6

#positioning

Preserved function exceeds the acknowledged culture limitations

The Abstract's intact-function conclusion rests on small, non-equivalence comparisons after culture expansion. The Discussion itself explains that expansion and dedifferentiation could make term-derived cells resemble non-pregnant cells.

↳ Abstract; Sections 3.2–3.3; Discussion, culture limitations

Does this match your read? Add your assessment ↓

Nabu Commentary

The clearest experimental result is increased PRL and IGFBP1 secretion after combined progestin–cAMP treatment, supporting a decidual response in cultured cells. Broader conclusions depend on contrasts that cannot isolate progesterone effects, track cell transition or directly measure changes in cell abundance. Positive myocyte staining in untreated controls and 20.3% CD45 positivity further constrain interpretation of stemness and surface phenotype. The Discussion engages conflicting literature and culture-induced dedifferentiation, but the Abstract's intact-function conclusion does not carry those qualifications.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.5±0.1

Contribution
3.0

The study adds term-decidua functional comparisons and post-stimulus surface-marker measurements to established work on SUSD2-positive cell decidualization. The advance is descriptive and incremental, with its transition and preservation interpretations limited by execution and identification problems.

Introduction; Sections 3.1–3.6; Discussion
Methodological Rigour
1.9

Donor-derived cultures, blinded histology and decidual-marker secretion provide evidence for selected within-system responses, but failed differentiation controls and mismatched contrasts undermine broader conclusions. The 20.3% CD45-positive population also conflicts with the stated MSC phenotype definition and is surfaced separately through the reliability flag.

Sections 2.4, 2.9, 3.2, 3.4–3.6; Figures 2, 4–6
Reporting
2.9

The experimental sequence is followable, but progression wording exceeds the reported pregnancy-group comparisons. Missing assay details and inconsistent treatment terminology reduce precision despite the conventional structure.

Abstract; Sections 2.9, 2.14 and 3.1; Figures 1–2
Positioning
2.8

The Discussion engages conflicting findings and explains culture-selection and dedifferentiation limitations. Those qualifications are not preserved in the Abstract's claim that function remains intact.

Abstract, final sentence; Discussion, prior-study comparisons and culture limitations

Lower confidence on Methodological Rigour, Reporting — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkNoted
  • Our results suggest that SUSD2+ eMSC undergo decidualization in vitro, while maintaining MSC plasma membrane phenotype: "whereas on average, 20.3% cells were CD45 positive (Fig. 4)." (Section 3.4, paragraph 2) vs "the absence CD45 and CD34 expression (Dominici et al., 2006)" (Section 1, paragraph 1). Compare the reported 20.3% CD45-positive gated cells with the paper's stated absence-of-CD45 criterion for an MSC phenotype. → Not supported by the paper's own data
  • Progesterone treatment induced changes in the decidual gene expression profile in non-pregnant SUSD2+ eMSC: "IL1B1, BDNF, BMP2, KDR, GDF7, PTK2, FZD9 were upregulated" (Section 3.4 (qPCR results)) vs "also upregulated the expression of VEGF-A fourfold in progesterone treated compared with control" (Discussion, paragraph on VEGFR-2/KDR). Compare the significant-gene list, which includes KDR but not VEGFA, with the Discussion's fourfold VEGF-A assertion. → Effect on result unclear
Reporting and transparencyNoted

Ethics approval, consent and competing interests are declared. Statistical-test names are misreported, and assay-specific sample sizes for Figure 2A–B and the underlying SUSD2-negative qPCR results are not supplied.

Conflict of interest: declared · Ethics approval: declared

Reference IntegrityClean

67 references in manuscript 66 of 66 checkable references found in an index 1 could not be checked — not the same as no match found

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
CitationsFWCI 1.1
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim that SUSD2+ eMSC decidualize in vitro while retaining MSC membrane markers was demonstrated only under controlled laboratory culture conditions with in vitro assays and human tissue histology.

From the paper
“Hence, collecting MSC from caesarean section decidua could represent another way of collecting adult MSC in the future.”

The paper names a possible real-world use of its own findings, namely harvesting adult MSC from caesarean section decidua, but does not specify who would act on this or how it would be applied.

Pathway

Reproductive biologists and cell-therapy developers could use the insight that decidualized eMSC retain stemness to source adult MSC from caesarean decidua for regenerative therapies.

Barrier

The findings rest on small in vitro samples and the authors themselves call for further functional analyses of eMSC roles in angiogenesis, trophoblast invasion and implantation before any application.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature

    Silini, Di Pietro, Lang-Olip, et al. · 2020 · Basic medicine

    Primary claim

    The literature analysis we performed did not allow us to identify specific markers to uniquely identify the cell populations discussed herein. At the current time, this is a quasi impossible task due to the heterogeneity of the starting material

    Supported
    Evidence Score
    3.4±0.2
    Reliability
    No concerns
  2. Different regulation of IRE1α and eIF2α pathways by oxygen and insulin in ACH-3P trophoblast model

    Veronika Tandl, Denise Hoch, Julia Bandres-Meriz, et al. · 2021 · Basic medicine

    Primary claim

    Overall, our results suggest that IRE1α and eIF2α UPR-pathways are differentially regulated by oxygen and insulin [in ACH-3P trophoblast cells] in early pregnancy.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  3. The ALS- and FTD-associated proteins annexin A11 and CHMP2B act sequentially in plasma membrane repair

    Heffner, Starling, Straker, et al. · 2026 · Basic medicine

    Primary claim

    annexin proteins are recruited immediately and form a plug at the damage site, restricting membrane permeability

    Supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats

How the rubric works →